PSAR, Robert, Ondrej URBAN, Tomáš ROHAN, Michal STEPAN, Martin HILL and Marie CERNA. The role of abdominal ultrasonography in patients with isoattenuating pancreatic carcinoma. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2023, vol. 167, No 4, p. 352-356. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2022.032.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The role of abdominal ultrasonography in patients with isoattenuating pancreatic carcinoma
Authors PSAR, Robert (203 Czech Republic), Ondrej URBAN (203 Czech Republic), Tomáš ROHAN (203 Czech Republic, guarantor, belonging to the institution), Michal STEPAN (203 Czech Republic), Martin HILL (203 Czech Republic) and Marie CERNA (203 Czech Republic).
Edition Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2023, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30224 Radiology, nuclear medicine and medical imaging
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 0.900 in 2022
RIV identification code RIV/00216224:14110/23:00130239
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5507/bp.2022.032
UT WoS 000828168100001
Keywords in English pancreatic cancer; isoattenuating; ultrasound; ultrasonography; computed tomography; endoscopic ultrasonography
Tags 14110216, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 26/1/2024 10:49.
Abstract
Aims. The main objective of this study was to determine the sensitivity of abdominal ultrasonography (US) in patients with isoattenuating pancreatic carcinoma and to compare the frequency of secondary signs on abdominal US and endoscopic ultrasonography (EUS) in these tumours. Methods. Twenty-four patients with histologically or cytologically verified isoattenuating pancreatic carcinoma who underwent abdominal US, contrast-enhanced CT and EUS of the pancreas as part of the diagnostic workup were included in this retrospective study. The sensitivity of abdominal US in detecting the isoattenuating pancreatic carcinoma was investigated and the frequency of secondary signs of isoattenuating pancreatic carcinoma on abdominal US and EUS was compared. Results. In 5 of 24 patients (21%) with isoattenuating pancreatic carcinoma, a hypoechogenic pancreatic lesion was directly visualised on abdominal US. Secondary signs were present on US in 21 patients (88%). These included dilatation of the common bile duct and/or intrahepatic bile ducts in 19/24 (79%), dilatation of the pancreatic duct in 3/24 (13%), abnormal contour/inhomogeneity of the pancreas in 1/24 (4%), and atrophy of the distal parenchyma in 1/24 (4%). Pancreatic duct dilatation was observed more frequently on EUS than on abdominal US (P=0.002). For other secondary signs, there was no significant difference in their detection on abdominal US and EUS (P=0.61-1.00). Conclusion. Abdominal US is capable of detecting secondary signs of isoattenuating pancreatic carcinoma with high sensitivity and has the potential to directly visualise these tumours.
PrintDisplayed: 26/4/2024 06:19